Skip to content
Screener

PP&E (Net) at other companies

Insulet logo
InsuletPODD
$858.6M+19.2%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$84.5M+9.0%
Medtronic logo
MedtronicMDT
$7.42B+8.5%
Embecta Corp. logo
Embecta Corp.EMBC
$316.8M+20.6%
AdaptHealth logo
AdaptHealthAHCO
$622.19M+29.2%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$49.76M+25.7%

Other financials

Income statement

See full
Revenue$32.0M+37.8%
Gross profit$18.9M+51.2%
Operating income-$25.6M-28.7%
Net income-$23.4M-38.7%
EPS (diluted)-$0.53-35.9%

Balance sheet

See full
Cash & equivalents$44.3M+26.4%
Total debt$6.5M-2.6%
Total equity$256.4M-15.0%
Total assets$292.4M-11.4%

Cash flow

See full
Operating cash flow-$14.6M-7.6%
CapEx$1.0M-41.6%
Free cash flow-$15.7M-1.9%

Valuation

See full
Market cap$715.34M+15.1%
Enterprise value$677.53M+14.2%
P/S-2.0×

Profitability

See full
Gross margin58.3%+4.4pp
Operating margin-69.8%-8.0pp
Net margin-61.3%-15.8pp
FCF margin-51.6%-13.4pp

Returns & leverage

See full
Return on equity-26.2%
Debt / equity0.0×
Current ratio8.9×-5.8×

Where this comes from

Reported directly by Beta Bionics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:20 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323777
Line itemJune 30,2026December 31,2025
Inventories23,91821,722
Prepaid expenses and other current assets8,4749,840
Total current assets231,034267,905
Property and equipment, net10,7488,600
Operating lease right-of-use asset5,8166,627
Long-term investments44,64845,431
Other long-term assets141180
Total assets$292,387$328,743

Item 1. Financial Statements.

FAQ

What is Beta Bionics's PP&E (net)?
Beta Bionics (BBNX) reported PP&E (net) of $10.75M in Q2 2026.
How has Beta Bionics's PP&E (net) changed year-over-year?
Beta Bionics's PP&E (net) increased by 66.2% year-over-year, from $6.47M to $10.75M.
What is the long-term trend for Beta Bionics's PP&E (net)?
Over 2 years (2023 to 2025), Beta Bionics's PP&E (net) has grown at a 86.4% compound annual growth rate (CAGR), from $2.48M to $8.6M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Beta Bionics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude